Cargando…
Long-term remission and biologic persistence rates: 12-year real-world data
BACKGROUND: Biologic therapies have greatly improved outcomes in rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Yet, our ability to predict long-term remission and persistence or continuation of therapy remains limited. This study explores predictors of remission and persistence of the ini...
Autores principales: | Murray, Kieran, Turk, Matthew, Alammari, Yousef, Young, Francis, Gallagher, Phil, Saber, Tajvur, Fearon, Ursula, Veale, Douglas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807520/ https://www.ncbi.nlm.nih.gov/pubmed/33441191 http://dx.doi.org/10.1186/s13075-020-02380-z |
Ejemplares similares
-
The effects of alcohol consumption and its associations with disease activity among 979 patients with inflammatory arthritis
por: Turk, Matthew, et al.
Publicado: (2021) -
Remission in psoriatic arthritis: is it possible and how can it be predicted?
por: Saber, Tajvur P, et al.
Publicado: (2010) -
Toll-Like Receptor 2 Induced Angiogenesis and Invasion Is Mediated through the Tie2 Signalling Pathway in Rheumatoid Arthritis
por: Saber, Tajvur, et al.
Publicado: (2011) -
IL-17A Expression Is Localised to Both Mononuclear and Polymorphonuclear Synovial Cell Infiltrates
por: Moran, Ellen M., et al.
Publicado: (2011) -
Rheumatoid arthritis CD14(+) monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease
por: McGarry, Trudy, et al.
Publicado: (2021)